A new study has found that transvaginal mesh fails nearly one third of all patients within 7 years of receiving the device. Published in the Journal of American Medical Association, the study followed 215 women who received transvaginal mesh to treat pelvic organ prolapse for 7 years.
About 1 in 4 women suffer from pelvic organ prolapse or stress urinary incontinence, and between 11% and 19% receive mesh surgery to correct it. However, of the 215 women in the study, nearly one third saw their problems return, with about 17% requiring additional surgery to correct transvaginal mesh complications.
Thousands of women have filed lawsuits against transvaginal mesh manufacturers including Johnson & Johnson and C.R. Bard. The transvaginal mesh lawsuits allege that companies released a defective product, which could cause severe complications, including internal bleeding, limited mobility, tissue damage and organ perforation.